AEGIS CARE SOLUTIONS LIMITED Company accounts

COMPANY REGISTRATION NUMBER: 10499073

AEGIS CARE SOLUTIONS LIMITED

Unaudited Financial Statements

30 November 2024

AEGIS CARE SOLUTIONS LIMITED

Financial Statements

Year ended 30 November 2024

Contents	Page

Director's report	1

Statement of income and retained earnings	2

Statement of financial position	3

Notes to the financial statements	5

AEGIS CARE SOLUTIONS LIMITED

Director's Report

Year ended 30 November 2024

The director presents his report and the unaudited financial statements of the company for the year ended 30 November 2024 .

Director

The director who served the company during the year was as follows:

Mr Johnson

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 28 November 2025 and signed on behalf of the board by:

Mr Johnson	Unity Business Centre
Director	Company Secretary

Registered office:

Unity Business Centre

26 Roundhay Road

Leeds

West Yorkshire

United Kingdom

LS7 1AB

AEGIS CARE SOLUTIONS LIMITED

Statement of Income and Retained Earnings

Year ended 30 November 2024

	2024
Note	£
Turnover	2,857,573

Cost of sales	199,999
	------------
Gross profit	2,657,574

Distribution costs	3,092
Administrative expenses	2,208,555
Other operating income	24,643
	------------
Operating profit	470,570

Interest payable and similar expenses		40,233
		------------
Profit before taxation	5	430,337

Tax on profit	81,764
	---------
Profit for the financial year and total comprehensive income	348,573
	---------

Retained losses at the start of the year	( 48,500)
	---------
Retained earnings at the end of the year	300,073
	---------

All the activities of the company are from continuing operations.

AEGIS CARE SOLUTIONS LIMITED

Statement of Financial Position

30 November 2024

	2024
Note	£	£

Fixed assets

Tangible assets	6		585,901

Current assets

Debtors	7	334,048
Cash at bank and in hand		82,774
		---------
		416,822

Creditors: amounts falling due within one year	8	30,631
		---------
Net current assets			386,191
			---------
Total assets less current liabilities			972,092

Creditors: amounts falling due after more than one year	9		383,326

Provisions

Pensions and similar obligations		7,345
		---------
Net assets		581,421
		---------

Capital and reserves

Other reserves		281,348
Profit and loss account		300,073
		---------
Shareholders funds		581,421
		---------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

AEGIS CARE SOLUTIONS LIMITED

Statement of Financial Position (continued)

30 November 2024

These financial statements were approved by the board of directors and authorised for issue on 28 November 2025 , and are signed on behalf of the board by:

Mr Johnson
Director

Company registration number: 10499073

AEGIS CARE SOLUTIONS LIMITED

Notes to the Financial Statements

Year ended 30 November 2024

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unity Business Centre , 26 Roundhay Road, Leeds, West Yorkshire, LS7 1AB, United Kingdom.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Transition to FRS 102

The entity transitioned from previous UK GAAP to FRS 102 as at 1 December 2022. Details of how FRS 102 has affected the reported financial position and financial performance is given in note 10.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

		-	25% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 49 .

5. Profit before taxation

Profit before taxation is stated after charging:

	2024
	£
Depreciation of tangible assets	32,500
	--------

6. Tangible assets

	Land and buildings	Fixtures and fittings	Motor vehicles	Equipment	Total
	£	£	£	£	£
Cost
At 1 December 2023 and 30 November 2024	479,663	3,405	130,000	5,333	618,401
	---------	-------	---------	-------	---------
Depreciation
At 1 December 2023 and 30 November 2024	–	–	32,500	–	32,500
	---------	-------	---------	-------	---------
Carrying amount
At 30 November 2024	479,663	3,405	97,500	5,333	585,901
	---------	-------	---------	-------	---------

7. Debtors

	2024
	£
Trade debtors	194,826
Other debtors	139,222
	---------
	334,048
	---------

8. Creditors: amounts falling due within one year

	2024
	£
Bank loans and overdrafts	1,438
Trade creditors	6,226
Social security and other taxes	153,628
Other creditors	( 130,661)
	---------
	30,631
	---------

9. Creditors: amounts falling due after more than one year

	2024
	£
Bank loans and overdrafts	( 86,424)
Other creditors - desc in a/cs	469,750
	---------
	383,326
	---------

10. Transition to FRS 102

These are the first financial statements that comply with FRS 102. The company transitioned to FRS 102 on 1 December 2022.

No transitional adjustments were required in equity or profit or loss for the year.